MedPath

Chronic Kidney Disease Knowledge and Awareness Among American Indians

Not Applicable
Completed
Conditions
Chronic Kidney Disease
Registration Number
NCT02309528
Lead Sponsor
The Cleveland Clinic
Brief Summary

Few educational intervention clinical trials have been conducted among those at risk for or with early chronic kidney disease. To the investigators' knowledge none have used digital storytelling as a means to deliver the educational message and have been conducted among American Indians, a group with high prevalence of chronic kidney disease and end stage kidney disease.

The aims of the research project are to:

1. Quantify levels of chronic kidney disease knowledge and awareness among American Indians.

2. Determine the effectiveness of a culturally tailored health presentation with computerized digital stories made by American Indians for improving chronic kidney disease knowledge and factors thought to be preventative of chronic kidney disease or its progression at baseline and follow-up in a pilot educational clinical intervention trial.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Strong Heart Study or Strong Heart Family Study participant
Exclusion Criteria
  • End Stage Renal Disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Chronic Kidney Disease Knowledgeup to 12 months

Survey of CKD Knowledge at baseline, post-intervention, 1-month follow up, 6 month follow up, and 12 month follow up

Secondary Outcome Measures
NameTimeMethod
Blood PressureSept 2014-Sept 2015, baseline, 1-month, 6-month, and 12-month follow-up

average resting blood pressure collected via automated BP machine which has 5 minute rest period, then collects BP at 1 minute intervals for 3 measurements, and then calculates an average

Self-reported doctor visits and hospitalizations1-month, 6-month, and 12-month follow-up

Survey collection of self-reported doctor visits or hospitalizations

Self-reported new medical conditions1-month, 6-month, and 12-month follow-up

Survey collection of self-reported new diagnoses (i.e. diabetes, hypertension)

Self-reported medication use and adherence1-month, 6-month, and 12-month follow-up

Self-reported non-steroidal anti-inflammatory use and self-reported medication adherence of diabetes and/or blood pressure medications via the Morisky Medication Adherence Scale (MMAS-4)

Trial Locations

Locations (1)

Cleveland Clinic

🇺🇸

Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath